Mass Spectrometry: An HPLC-MS/MS Assay Method for the Determination of Digoxin in Human Plasma and Urine
Digoxin is a cardiac glycoside which has been used for many years in the management of congestive heart failure and other cardiac diseases. An HPLCMS/ MS method was developed and validated according to current industry guidelines for the determination of digoxin in human plasma and urine. The calibration range of the plasma method was 0.100 to 10.0ng/mL and the range for the urine method was 1.00 to 100ng/mL. Digitoxigenin was used as the internal standard. The analytes were extracted from plasma and urine using solid phase extraction cartridges.
View Resource
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.